News
Compared with older control subjects, the late-onset AD group had a more focal pattern of grey matter volume loss in the medial temporal lobes, particularly the hippocampi. The DLB group also ...
A young, 31-year-old British woman died of a rare form of dementia that set in when she was in her late 20s. Gemma ...
Alterity’s previous interactions with the FDA indicated that the modified Unified Multiple System Atrophy Rating Scale (UMSARS) Part I scale is considered a clinically meaningful endpoint for MSA.
Gemma Illingworth, from Manchester, was diagnosed with posterior cortical atrophy (PCA), a rare form of dementia, in 2021, while working from home during the pandemic. She died in November last ...
From birth to the last moments of life, the human brain is known to change and evolve significantly, both in terms of its ...
Alterity's previous interactions with the FDA indicated that the modified Unified Multiple System Atrophy Rating Scale (UMSARS) Part I scale is considered a clinically meaningful endpoint for MSA.
People in the UK are increasingly propping up multiple generations of their families, placing significant pressure on their own financial wellbeing, according to the latest Saltus Wealth Index Report.
Apellis Pharma has become the first company to claim FDA approval for a drug to treat geographic atrophy (GA), a sight-robbing condition that accompanies age-related macular degeneration (AMD ...
Astellas confirmed today that it will withdraw its EMA filing for avacincaptad pegol as a treatment for eye disorder geographic atrophy (GA), based on feedback from the EU regulator. It is a major ...
GABAB receptors contribute to complex inhibition that regulates cortical neurons in a translationally relevant manner over adult life. Here, authors show stronger presynaptic inhibition in humans ...
Malformations of cortical development are commonly associated with epilepsy and intellectual disabilities. Polymicrogyria is one of the most frequent cortical malformations but remains largely ...
If you already have a place in this event but would like to support Alzheimer’s Research UK, we’d love to have you on the team! There’s no minimum sponsorship target and we can provide help and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results